Unlike HGH, AOD 9604 has no growth-promoting effects, which makes it safer to use as part of a targeted therapy plan
These include, extreme tiredness, a lack of energy, pins and needles, muscle weakness, disturbed vision, mouth ulcers, a sore and red tongue, and cognitive or psychological concerns such as depression, confusion, and difficulty with memory, understanding or judgement
First, visibility
Unopened vials should be stored upright to reduce the risk of seal compromise or leakage
For depot formulations (sustained-release peptide suspensions), IM provides a reservoir effect that prolongs absorption
Both ultimately raise endogenous growth hormone and IGF-1 levels, placing them mechanistically closer to Tesamorelin than to AOD-9604, which was specifically designed to avoid GH/IGF-1 involvement altogether